SJURVM schreef op 30 mei 2017 13:27:
More than year on and what can we say about our European sales team results?
IRVINE, Calif. and HERSTAL, Belgium, March 9, 2016 (GLOBE NEWSWIRE) -- MDxHealth SA (Euronext: MDXH.BR) announced today that it has appointed a global commercial team to drive the launch of the Company's new non-invasive, urine-based test, SelectMDx(TM) for Prostate Cancer.
MDxHealth is employing a direct sales strategy for the SelectMDx test in the Benelux, Germany and Italy, supported by European and global distributors and commercial lab partners. The team will be led by Mr. Brett A. Swansiger, Senior Vice President of Business Development, who will oversee the global commercialization strategy for SelectMDx.
The European sales team includes industry veterans, Mr. George Skinner, Senior Director European Commercial Operations, based in Germany, Mr. Harry Rentrop, Sales Director, Benelux and Dr. Maurizio Ballerini M.D., Sales Director, Italy.